Northwestern, AbbVie partner to research cancer therapies
A new collaboration between two Chicago healthcare entities will provide a platform to conduct ongoing cancer research.
AbbVie and Northwestern University have agreed to a five-year collaboration in which Northwestern’s Lurie Cancer Center will be able to access new therapies made by AbbVie. The collaboration will focus on lung, colorectal, breast, prostate and blood cancers, according to a recent report from Crain’s Chicago Business.
In addition to working with Northwestern, AbbVie has announced similar collaborations with Johns Hopkins University School of Medicine in Baltimore and the University of Chicago.
To read more about the partnerships, follow the link below: